What's happening
This bill requires opioid prescription bottles in New York to have a warning label stating the drug is highly addictive.
Why it matters
Aims to increase patient awareness of addiction risks. By requiring a clear warning label about opioid addiction on every prescription bottle, this bill targets the gap in patient knowledge that can lead to misuse or accidental dependency.
May influence patient behavior and decision-making. The explicit warning and instruction to consult a pharmacist or physician could prompt patients to ask more questions and seek guidance about the risks and alternatives, potentially leading to more cautious use.
Could affect prescribers and pharmacists. With the legal requirement for this warning, pharmacists and prescribers may need to spend more time discussing opioid risks with patients, which could change workflows or prompt additional training and communication efforts.
Part of broader public health and opioid crisis response. This labeling mandate reflects ongoing efforts to curb opioid addiction and overdose rates in New York, signaling heightened state intervention and responsibility in informing and protecting consumers.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pharmacies dispensing opioids
They would need to affix a legible warning label to opioid containers stating that the drug is highly addictive and advising consultation with a pharmacist or physician before use.
Patients receiving prescription opioids
They would receive an explicit addiction warning and advice to consult a pharmacist or physician before using the drug.
Pharmacists and physicians
The required label would direct patients to them for consultation before using prescribed opioids.
Headline styles
Warn Opioid Users on Bottles
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 26
1 Co-sponsor
History
- Referred to health
- Referred to health
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1022
2023-2024 Regular Sessions
IN ASSEMBLY
January 13, 2023
Introduced by M. of A. BRAUNSTEIN, SEAWRIGHT -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 3333 of the public health law is amended by adding a new paragraph (d) to read as follows:
(d) In addition to the other requirements of this subdivision, where the controlled substance being dispensed is an opioid, there shall be affixed to the container a label upon which is indelibly typed, printed, or otherwise legibly written "Warning. This drug is highly addictive. Please consult your pharmacist or physician before using."
§ 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01206-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.